Abstract
OXACILLIN SODIUM has been demonstrated to effectively inhibit penicillin-sensitive and resistant staphylococci in vitro at concentrations readily obtainable in vivo 1 and together with other similar penicillinase-resistant penicillins, is considered a drug of choice in staphylococcal infection. 2 As young infants are particularly susceptible to staphylococcal infection, information concerning the effectiveness of oxacillin sodium in treating such infections and the pharmacology of oxacillin sodium in such patients is needed. The study reported herein provides information regarding the serum concentrations of oxacillin sodium achieved with varying dosage schedules in young infants, the effectiveness of the drug in the treatment of severe staphylococcal infection in this age group, and the toxicity of the drug in newborns and in older infants. Material and Methods All patients less than 2 years of age admitted to the service wards or nurseries of the Department of Pediatrics, Mercy Hospital during the period July 1, 1963, to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
